Cogent Biosciences, Inc.
COGT
$4.98
$0.265.51%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -14.43% | -14.44% | -7.63% | -16.64% | 63.99% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -23.12% | 56.35% | -11.04% | 9.61% | 21.77% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -14.70% | -13.19% | -7.69% | -16.28% | 63.20% |
|
|
|||||
| Total Current Assets | -14.70% | -13.19% | -7.69% | -16.28% | 63.20% |
| Net Property, Plant & Equipment | -1.93% | -3.74% | -2.88% | -3.18% | -3.28% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | -0.04% |
| Total Assets | -13.45% | -14.61% | -10.68% | -9.70% | 51.90% |
|
|
|||||
| Total Accounts Payable | 17.82% | -20.24% | 67.81% | -42.34% | 46.08% |
| Total Accrued Expenses | -60.58% | 131.99% | 23.41% | 53.79% | -25.82% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.94% | 2.96% | 3.05% | 3.00% | 3.32% |
| Total Finance Division Other Current Liabilities | 29.76% | 21.90% | 21.43% | -60.38% | 44.22% |
| Total Other Current Liabilities | 29.76% | 21.90% | 21.43% | -60.38% | 44.22% |
| Total Current Liabilities | -11.47% | 5.02% | 32.61% | 9.04% | -3.88% |
|
|
|||||
| Total Current Liabilities | -11.47% | 5.02% | 32.61% | 9.04% | -3.88% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.65% | -2.50% | -2.39% | -2.24% | -2.15% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -9.51% | 3.25% | 22.30% | 5.46% | -3.34% |
|
|
|||||
| Common Stock & APIC | 3.72% | 1.01% | 1.48% | 13.69% | 7.62% |
| Retained Earnings | -8.38% | -8.58% | -9.80% | -8.91% | -9.67% |
| Treasury Stock & Other | -63.31% | -50.11% | 566.67% | -392.31% | -115.85% |
| Total Common Equity | -23.93% | -28.61% | -21.24% | 29.43% | 1.22% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -2.20% | 0.00% | -3.08% | -48.63% | 270.04% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -2.20% | 0.00% | -3.08% | -48.63% | 270.04% |
|
|
|||||
| Total Common Equity | -23.93% | -28.61% | -21.24% | 29.43% | 1.22% |
| Total Preferred Equity | -2.20% | 0.00% | -3.08% | -48.63% | 270.04% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -14.55% | -18.55% | -15.69% | -11.63% | 63.82% |
|
|
|||||